Implementation of Systematic Programs of Overdose Training at Drug Treatment and Prevention Centres in Catalonia,

Size: px
Start display at page:

Download "Implementation of Systematic Programs of Overdose Training at Drug Treatment and Prevention Centres in Catalonia, 2008 2013"

Transcription

1 Implementation of Systematic Programs of Overdose Training in Catalonia Implementation of Systematic Programs of Overdose Training at Drug Treatment and Prevention Centres in Catalonia, Albert Espelt 1,2,3 ; Xavier Major 4 ; Oleguer Parés-Badell 1 ; Sonia Carvajal 4 ; Carmen Vecino 1 ; Laia Gasulla 4 ; Marina Bosque-Prous 1 ; M. Teresa Brugal 1 Abstract Death due to overdose is a leading cause of death among people aged 15 to 44. Among drug users, there is a general lack of understanding of the risk factors that can lead to overdose and how to act when witnessing one. Thus, the Department of Drug Prevention and Care of the Catalan Government and the Public Health Agency of Barcelona have designed and deployed systematic training programs to increase understanding of overdose among drug users in Catalonia. The aim of this article is to describe these systematic programs of overdose training, and present data collected between 2009 and These programs have been successfully implemented in the majority of harm reduction centres, treatment centres and therapeutic communities in Catalonia. To date, training programs involving 4,828 drug users and 907 professionals have been conducted since the implementation of this strategy. 1 Introduction Death due to overdose is a leading cause of death among people aged 15 to 44 years. In this age group, it was the main cause of death among men and the second in women in Barcelona in 2011, with a mortality rate of 9 and 3.2 per 100,000 person-years, respectively (Agència de Salut Pública de Barcelona 2013). Almost a third of overdose deaths are caused by cocaine, while the remaining two thirds are caused by opiods (Bernstein/Bucciarelli/ Piper/Gross/Tardiff/Galea 2007). 1 Agència de Salut Pública de Barcelona. 2 Departament de Piscobiologia i Metodologia de la Universitat Autònoma de Barcelona. 3 CIBER de Epidemiologia y Salud Pública. 4 Departament de Salut de la Generalitat de Catalunya. Implementation of Systematic Programs of Overdose Training in Catalonia

2 84 3 Praxis in Europa Overdoses can be fatal or non-fatal. Thus, not only can overdoses be avoided, but also death can be avoided in individuals who have overdosed. Each year, between 9 and 22% (see Brugal/Barrio/Regidor/Royuela/Suelves 2002, Darke/ Ross/Hall 1996, Gossop/Griffiths/Powis/Williamson/Strang 1996) of heroin users suffer at least one non-fatal overdose (see Brugal/Barrio/Regidor/Royuela/Suelves 2002, Darke/Ross/Hall 1996, Gossop/Griffiths/Powis/Williamson/Strang 1996), whereas it varies from 3 to 9% in cocaine users, depending on the administration route (Kaye/Darke 2004). At any rate, overdoses can be prevented by taking their risk factors and behaviours into account, and can be reversed using simple measures when they do occur. Between 2 and 6% of all overdoses result in the death of the person, with this percentage depending on the population studied (Darke/Ross/Hall 1996, Darke/Mattick/Degenhardt 2003, Neale 2003, Espelt/Barrio/Álamo-Junquera et al. 2015). Among drug users, there is a general lack of understanding of the risk factors that can lead to overdose and how to act when witnessing one. We previously reported that young heroin users in Madrid, Seville and Barcelona had little knowledge of how to prevent an overdose (Neira-Leon/Barrio/Brugal/Ballesta/ Bravo et al. 2006), and that 29% of users at Harm Reduction Centres in Catalonia in 2008 were not able to give more than two reasons or actions for preventing overdoses or helping a person suffering an overdose. This poor level of understanding may be due to the lack of information programs and courses on this topic, which is supported by the fact that 73% of users of Harm Reduction Centres in Catalonia in 2008 reported that they had never attended an overdose prevention course (Sarasa-Renedo/Espelt/Folch/Vecino/Majó/ Castellano et al. 2014). Heroin overdose prevention and assistance programs have been effective in increasing understanding among intravenous drug users in various settings (Seal/Thawley/Gee/Bamberger/Kral/Ciccarone et al. 2005, Tobin/Sherman/ Beilenson/Welsh/Latkin 2009, Wagner/Valente/Casanova/Partovi/Mendenhall/ Hundley et al. 2010). Even in San Francisco, where users did not generally appear to apply the knowledge acquired from overdose programs, intravenous drugs users were very positive about participating in the prevention programs (Seal/Downing/Kral/Singleton-Banks/Hammond/Lorvick et al. 2003). At the beginning of the last decade, overdose prevention and harm reduction programs were developed in the Can Tunis neighbourhood of Barcelona in response to the high mortality from overdose in this area (Illundain 2006). However, these programs were not systematic and did not cover the entire city. Subsequently, due to the high number of injectors and growing evidence on the effectiveness of these programs, a systematic overdose prevention and assistance program was implemented throughout Catalonia in 2009.

3 Implementation of Systematic Programs of Overdose Training in Catalonia The aim of this article is to describe these systematic programs of overdose training, which were promoted by the Department of Drug Prevention and Care of the Catalan Government and Public Health Agency of Barcelona, and to present data collected between 2009 and Overdose Programs 2.1 Systematic overdose prevention programs in Catalonia Systematic overdose prevention programs are individual or group courses that are carried out regularly, and have been deployed throughout the Catalan network of drug prevention and treatment centres (i.e. harm reduction centres, drug treatment centres and therapeutic communities) since Currently, we are seeking to incorporate hospital detoxification and dual pathology units. In order to conduct systematic intervention, it is necessary that all centres have a protocol and a staff member responsible for implementing the program. Moreover, an annual meeting is held with these individuals to assess the implementation process and to establish annual coverage goals. Simultaneously, face-to-face and online training programs are offered to professionals at all centres. In addition, the protocol indicates that each centre must hold a clinical or scientific session about the program. 2.2 Aims of overdose prevention programs in Catalonia The main objectives of the overdose prevention programs are: 1) to reduce the number of opioid and psychostimulant overdoses; and 2) to reduce overdose mortality. The programs aim first to improve understanding of risky situations associated with drug overdose and how to prevent them, and second to improve the skills required to identify an overdose and knowledge of how to act when witnessing an overdose. 2.3 Target population of overdose prevention programs in Catalonia The main target population of these programs is users of opioid and pyschostimulant. However, the programs are also offered to relatives or friends who live with drug users, and people who may come into contact with

4 86 3 Praxis in Europa them at work. All persons registered for each program must give written informed consent, commit to attending the entire program, and not consume substances during the program. 2.4 Methodology of the Program Sessions and Materials The training program consists of a course, which can be conducted individually or in groups. Participants are trained in the various risk situations that can lead to overdose, emphasizing the personal risks of each user and recommending individual strategies to prevent overdoses. They also work on how to identify an overdose, and actions to perform when witnessing a cocaine or heroin overdose. This final section of the course is a practical exercise, with a role-playing game in which users come into contact with the material to be used and the problems that may arise. During the course, symptoms of overdoses of depressant drugs (focusing on heroin) and stimulating drugs (focusing on cocaine), and actions that may be taken are explained separately. Users understanding is evaluated at both the beginning and end of the course. Group courses are held mostly in harm reduction centres, and include about five participants. Individual sessions are mainly held in treatment centres, and are performed when a preliminary assessment of the user is needed to address their personal risk factors. These individual sessions can also be done in the street, but then the contents must be simplified and they must be focussed on the person s status. This training is facilitated by a short guide on counselling for heroin and cocaine overdose (Table 1). Increasingly, people opt for more flexible training that is adapted to individual circumstances in order to reach the most at-risk users, many of which are unable to attend formal courses. Once training is completed, participants complete a short questionnaire to assess whether they have acquired a basic understanding of overdose prevention and assistance, including the characteristics and use of naloxone. Participants who pass the test receive a naloxone kit (Figure 1) that allows them to act in case of a heroin overdose. The kit includes: two 1ml bottles of naloxone (0.4mg/ml), two retractable syringes, 1 pair of gloves, a protective mask for basic life support, two antiseptic wipes, and a prospectus. Thus, users become part of the naloxone program and must notify the centre of any use or loss of this substance. They are also given a card identifying them as an

5 Implementation of Systematic Programs of Overdose Training in Catalonia Overdose Health Agent, valid for 1 year (Figure 2), with the aim the users reassess their knowledge once a year, and undergo reinforcement training, if necessary. This reinforces their knowledge, and considers any difficulties that may be experienced by users. Figure 1. Naloxone kit

6 88 3 Praxis in Europa Personnel The courses are taught by two professionals with experience in overdose treatment and communication with users of intravenous drugs. In all cases, one is a health professional (doctor or nurse) and the other is a social worker. They receive an information manual on the prevention and treatment of overdoses (Majó/Illundain/Valverde 2009), a guide containing key points (Table 2), a slide presentation to use during the course, and a video 1 as support material, which addresses all of the issues that they have to deal with. Each centre must assign a 1 sobredosi/

7 Implementation of Systematic Programs of Overdose Training in Catalonia person responsible for the program and another in charge of its clinical aspects. Both functions can be served by the same professional, although in this case the person must be a doctor or a nurse. Each centre has some freedom to adapt itself to the general protocol, i.e. professionals in each centre can decide whether they do individual or group training, where the courses will be held, etc. The reason for this flexibility is that the program intends to be close to the personnel, to involve them in training strategies to identify the problem, to encourage them to suggest solutions and recommendations, and to take part in deploying the actions using contents and formats that they find acceptable. Thus, a key requirement is that each centre establishes an annual plan for training.

8 90 3 Praxis in Europa Evaluation and Incentives Throughout the learning process, participants in the overdose courses are evaluated three times. The course begins with an evaluation that is useful for the organisers to establish areas of lack of knowledge or specific skills in each group, and to compare participants knowledge before and after the course. At the end of the course, therefore, participants knowledge and behaviour related to opioid and psychostimulant overdose are evaluated, in order to decide whether they can receive the naloxone kit and the Overdose Health Agent card (Figure 2). The card identifies users who are experts in overdose, and allows them to obtain a reward of 5 to 10 for having taken part in the course. The evaluation is informally repeated a year later. If a lack of knowledge or skills is detected, the person can repeat the course. Figure 2. Overdose Health Agent card 3 Methods We performed a descriptive study, which had the following aims: a) to describe how to conduct overdose prevention training programs; b) to analyse the number of professional and users that have received overdose training in Catalonia; and c) to show the number of naloxone kits that have been delivered thanks to the overdose training program. This analysis included all participants in the overdose training program offered at harm reduction centres, treatment centres and therapeutic communities in Catalonia between 2009 and For each type of centre, we calculated the number of trained professionals, the number of trained users and the number of naloxone kits delivered.

9 Implementation of Systematic Programs of Overdose Training in Catalonia Results In Catalonia, there are 26 harm reduction centres, 64 treatment centres, and 17 therapeutic communities, 100% (26), 36% (23) and 88% (15) of which applied the overdose prevention training program in 2013, respectively. This program was introduced in harm reduction centres in March 2009, in therapeutic communities in 2010, and in treatment centres in January During the period , 508 professionals and 2,049 drug users were trained in harm reduction centres. In total, 4,383 naloxone kits were delivered, i.e. more than one naloxone kit for each user trained. However, in 2012 more than 30% of users trained at harm reduction centres did not receive the kit (Table 3). Regarding treatment centres, 168 professionals and 981 patients were trained between 2011 and 2013, and 987 naloxone kits were delivered (Table 4). Finally, 231 professionals and 1,798 users were trained at therapeutic communities between 2010 and 2013, although naloxone kits were not distributed at these centres (Table 5).

10 92 3 Praxis in Europa 5 Discussion Systematic overdose training programs have been successfully implemented in the majority of harm reduction centres, treatment centres and therapeutic communities in Catalonia. These training programs have reached 4,828 users and 907 professionals, allowing them to increase their knowledge on overdose-risk situations associated with drug use and how to prevent them. In addition, these courses have provided the participants with tools such as cardiopulmonary reanimation and the naloxone kit, which may prevent death in case of overdose (Baca/Grant 2005, Dietze/Cantwell/Burgess 2002). Finally, the courses have helped many professionals maintain more direct and constant contact with drug users. Systematic overdose training programs are structured, formal and, generally programmed interventions. The materials used have facilitated good maintenance over time, guaranteeing the sustainability of the program and ensuring re-evaluation of users knowledge at least once a year. The cost of the program is minimized by using the centres existing infrastructure since these workshops are self-managed by the centres and the professionals who work there. Thus, the only direct cost of the program is the naloxone kit (~ 6/ kit) and the replacement of bottles and syringes ( 1.3/bottle naloxone). Thus, the total cost of implementation was 31, for the period (~5,000 /year), dedicated exclusively to the naloxone kits. However, the total deployment of the courses includes other expenses, as follows for the period : specific personnel (103,607 ), graphic material (34,591 ), mannequins (2,787 ) and user incentives (20,000 ). Specific costs for personnel do not include those for personnel from the Department of Drug Prevention and Care of the Catalan Government or Barcelona Public Health Agency, who managed the design and implementation of the entire program.

11 Implementation of Systematic Programs of Overdose Training in Catalonia During the design of the training program, support material for professionals was assessed using a test designed ad hoc. However, self-management of these courses carried some difficulties, such as lack of time to carry them out within working hours, or the lack of necessary infrastructure in some centres. Some users had difficulty in keeping scheduled appointments or were reluctant to attend courses, especially in harm reduction centres. When were performed in groups, the sessions were very long, and some users may not have been able to follow them. Thus, it is important to develop short, flexible, individual sessions, and we also recommend the introduction of peer training. These two changes would allow us to reach more users, especially those with higher risk of acute poisoning. Since overdose is one of the leading causes of death in men aged 15 to 44 years in Barcelona, it is essential to act in people who may be exposed. Overdose training programs can be implemented in different contexts, using existing resources and with little extra cost for the services offered to drug addicts. Since overdoses are preventable and reversible if treated properly, it is essential to increase understanding and skills of users and other actors, in order to help when assisting others. It is also important that all centres systematically assess the individual overdose risk of each patient, and include the results of this evaluation in their medical record. There are also moments in the addiction treatment process in which risk of overdose is higher and, thus, preventive interventions are essential at these times. Many professionals often have little awareness of the importance of developing measures of risk detection and overdose prevention, especially those in centres designed to treat addiction, whereas those in harm reduction centres are usually more aware. Centres focused on abstinence-oriented treatment should prioritize this intervention, since the loss of tolerance is one of the most important risk factors for overdose. Moreover, we have also observed groups of patients who are less aware of their overdose risk. We also believe that a formal evaluation of the intervention is needed. It is important to know whether there is real improvement in users knowledge and skills, and if the overdose training courses meet their objectives. The proportion of the material provided to users that is finally used when they witness an overdose, or an increase in the number of emergency calls from people witnessing an overdose are indicators of the proper functioning of this systematic program. Moreover, it will be important to assess the possibility that this overdose prevention program can have harmful side effects, such as the security offered by the use of naloxone, which may increase the dose of heroin consumed or reduce the number of calls to emergency services when witnessing an overdose.

12 94 3 Praxis in Europa Finally, we were unable to provide naloxone kits to all users who attended the overdose training program, especially in therapeutic communities, mainly because treatment centres that are focused on abstinence consider being offered a naloxone kit while in treatment to be contradictory. One of the greatest advantages of the overdose training program is that it has reached a large proportion of users. In this regard, a recent study (Arribas-Ibar/ Sánchez-Niubò/Majó/Domingo-Salvany/Brugal 2014) found that 43.5% (95% CI: 37-49%) of drug users in Catalonia have participated in an overdose prevention course. This percentage differs depending on whether the patients were in treatment (32.1%), in therapeutic communities (35.2%), or users of harm reduction centres (66.7%). Given these percentages, it is needed to promote systematic overdose prevention programs in treatment centres and therapeutic communities. Moreover, it could be advisable to deploy this program in prisons, since drug users have a higher risk of a drug-related death once they are released (Bird/Hutchinson 2003). Acknowledgements Part of this paper was supported by the Spanish Network on Addictive Disorders [grant numbers RD06/0001/1018 and RD12/0028/0018]. Staf f from the Xarxa d Atenció a les Drogodependències de Catalunya (Catalan Drug Care Centres Network). References Agencia de Salut Pública de Barcelona (2013): Agencia de Salut Pública. La Salut a Barcelona Online: pdf [ ]. Arribas-Ibar/Sánchez-Niubò/Majó/Domingo-Salvany/Brugal (2014): Coverage of overdose prevention programs for opiate users and injectors: a cross-sectional study. In: Harm Reduct J 11(1): 33. Baca/Grant (2005): Take-home naloxone to reduce heroin death. In: Addiction 100(12): Bernstein/Bucciarelli/Piper/Gross/Tardiff/Galea (2007): Cocaine- and opiaterelated fatal overdose in New York city, In: BMC Public Health 7: 31. Bird/Hutchinson (2003): Male drugs-related deaths in the fortnight after release from prison: Scotland, In: Addiction 98(2): Brugal/Barrio/Regidor/Royuela/Suelves (2002): Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration. In: Addiction 91(3):

13 Implementation of Systematic Programs of Overdose Training in Catalonia Darke/Ross/Hall (1996): Overdose among heroin users in Sydney, Australia: II. responses to overdose. In: Addiction 91(3): Darke/Mattick/Degenhardt (2003): The ratio of non-fatal to fatal heroin overdose. In: Addiction 98(8): Dietze/Cantwell/Burgess (2002): Bystander resuscitation attempts at heroin overdose: does it improve outcomes? In: Drug Alcohol Depend 67(2): Espelt/Barrio/Álamo-Junquera/Bravo/Sarasa-Renedo/Vallejo/Molist/Brugal (2015): Lethality of Opioid Overdose in a Community Cohort of Young Heroin Users. In: Eur Addict Res 21 (6): Gossop/Griffiths/Powis/Williamson/Strang (1996): Frequency of non-fatal heroin overdose: survey of heroin users recruited in non-clinical settings. In: BMJ 313: 402. Illundain (2006): Drogas, enfermedad y exclusión. Can Tunis (Barcelona) como paradigma? In: Monografias Humanitas. 2006(5): Kaye/Darke (2004): Non-fatal cocaine overdose among injecting and non-injecting cocaine users in Sydney, Australia. In: Addiction 99(10): Neale (2003): The ratio of non-fatal to fatal heroin overdose. In: Addiction 98(8): Majó/Illundain/Valverde (2009): Manual per educar en prevenció i assistència a les sobredosis. Adreçat als professionals de les drogodependències. Generalitat de Catalunya. Barcelona, Neira-Leon/Barrio/Brugal/Ballesta/Bravo et al. (2006): Do young heroin users in Madrid, Barcelona and Seville have sufficient knowledge of the risk factors for unintentional opioid overdose? In: J Urban Health 83(3): Seal/Downing/Kral/Singleton-Banks/Hammond/Lor vick et al. (2003): Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area. In: J Urban Health 80(2): Sarasa-Renedo/Espelt/Folch/Vecino/Majó/Castellano (2014): Overdose prevention in injecting opioid users: the role of substance abuse treatment and training programs. In: Gac Sanit 28: Seal/Thawley/Gee/Bamberger/Kral/Ciccarone et al. (2005): Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study. In: J Urban Health 82(2): Tobin et al. (2009): Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. In: Int. J Drug Policy 20(2): Wagner/Valente/Casanova/Partyi/Mendenhall/Hundley et al. (2010): Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. In: Int. J Drug Policy 21(3):

A Cost-Effectiveness Study of Toronto Public Health s Preventing Overdose in Toronto (POINT) Program

A Cost-Effectiveness Study of Toronto Public Health s Preventing Overdose in Toronto (POINT) Program A Cost-Effectiveness Study of Toronto Public Health s Preventing Overdose in Toronto (POINT) Program Dima Saab, Lady Bolongaita, Jennifer Innis 2013 Annual CAHSPR Conference May 29, 2013: Vancouver, B.C.

More information

APPENDIX: Key summary of six US-based naloxone distribution programs

APPENDIX: Key summary of six US-based naloxone distribution programs Distinguishing signs of opioid overdose and indication for naloxone: An evaluation of six naloxone training and distribution programs in the United States Traci C. Green, Robert Heimer, Lauretta E. Grau

More information

Naloxone: Overview, Criminal Justice and other Special Settings

Naloxone: Overview, Criminal Justice and other Special Settings Naloxone: Overview, Criminal Justice and other Special Settings Ingrid Binswanger, MD, MPH, MS Division of General Internal Medicine Affiliated Member, Division of Substance Dependence University of Colorado

More information

Overdoses among friends: Drug users are willing to administer naloxone to others

Overdoses among friends: Drug users are willing to administer naloxone to others Journal of Substance Abuse Treatment 30 (2006) 129 133 Overdoses among friends: Drug users are willing to administer naloxone to others Tara Lagu, (M.D.), Bradley J. Anderson, (Ph.D), Michael Stein, (M.D.)4,1

More information

the nta overdose and naloxone training programme for families and carers

the nta overdose and naloxone training programme for families and carers Pilot sites trained the carers and relations of opiate misusers to respond to overdoses and use the antidote naloxone. This appears to have helped save lives the nta overdose and naloxone training programme

More information

Objectives. Background

Objectives. Background Development and Implementation of a Pharmacist-Managed Intranasal Naloxone Distribution Program in a Veterans Affairs Healthcare Facility and Associated Community Clinics Innovative Practices Award Finalist

More information

JAN 2 7 2016. poisonings, commonly referred to as drug overdoses, are one of. the leading causes of injury-related mortality in Hawaii.

JAN 2 7 2016. poisonings, commonly referred to as drug overdoses, are one of. the leading causes of injury-related mortality in Hawaii. THE SENATE TWENTY-EIGHTH LEGISLATURE, 0 STATE OF HAWAII JAN 0 A BILL FOR AN ACT S.B. NO. % RELATING TO DRUG OVERDOSE PREVENTION BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII: 0 SECTION. The legislature

More information

Preventing Fatal Opioid Overdose Among Injection Drug Users. Skye Tikkanen Connections Counseling Scott Stokes AIDS Resource Center of Wisconsin

Preventing Fatal Opioid Overdose Among Injection Drug Users. Skye Tikkanen Connections Counseling Scott Stokes AIDS Resource Center of Wisconsin Preventing Fatal Opioid Overdose Among Injection Drug Users Skye Tikkanen Connections Counseling Scott Stokes AIDS Resource Center of Wisconsin I have no relevant financial interests to disclose for this

More information

How can we prevent heroin/opiate overdose deaths?: the contribution of pre-provided naloxone

How can we prevent heroin/opiate overdose deaths?: the contribution of pre-provided naloxone How can we prevent heroin/opiate overdose deaths?: the contribution of pre-provided naloxone Professor John Strang National Addiction Centre, London, UK Declaration (personal & institutional) DH, NTA,

More information

Testimony of. Daliah Heller, PhD, MPH Assistant Commissioner Bureau of Alcohol and Drug Use Prevention, Care and Treatment

Testimony of. Daliah Heller, PhD, MPH Assistant Commissioner Bureau of Alcohol and Drug Use Prevention, Care and Treatment Testimony of Daliah Heller, PhD, MPH Assistant Commissioner Bureau of Alcohol and Drug Use Prevention, Care and Treatment New York City Department of Health and Mental Hygiene before the New York City

More information

Testimony of The New York City Department of Health and Mental Hygiene. before the

Testimony of The New York City Department of Health and Mental Hygiene. before the Testimony of The New York City Department of Health and Mental Hygiene before the New York City State Assembly Committee on Alcoholism and Drug Abuse on Programs and Services for the Treatment of Opioid

More information

Scientific Facts on. Psychoactive Drugs. Tobacco, Alcohol, and Illicit Substances

Scientific Facts on. Psychoactive Drugs. Tobacco, Alcohol, and Illicit Substances page 1/5 Scientific Facts on Psychoactive Drugs Tobacco, Alcohol, and Illicit Substances Source document: WHO (2004) Summary & Details: GreenFacts Context - Psychoactive drugs such as tobacco, alcohol,

More information

LONG-TERM TREATMENT OUTCOME: WHAT ARE THE 11 YEAR OUTCOMES OF TREATMENT FOR HEROIN DEPENDENCE?

LONG-TERM TREATMENT OUTCOME: WHAT ARE THE 11 YEAR OUTCOMES OF TREATMENT FOR HEROIN DEPENDENCE? AUSTRALIAN T R E A T M E N T OU T C O M E STUDY - N S W Funded by the National Health and Medical Research Council and the Australian Government Department of Health. ATOS NSW is a project of the Centre

More information

Development of the guidelines on the pharmacotherapy of addiction case study Croatia

Development of the guidelines on the pharmacotherapy of addiction case study Croatia Development of the guidelines on the pharmacotherapy of addiction case study Croatia Croatia Marina Kuzman Dragica Katalinic Croatian National Institute of Public Health Cyprus, 2009. Drug use and drug

More information

OPIOID OVERDOSE RESPONSE AND NALOXONE ADMINISTRATION

OPIOID OVERDOSE RESPONSE AND NALOXONE ADMINISTRATION 1.0 Purpose OPIOID OVERDOSE RESPONSE AND NALOXONE ADMINISTRATION This is a DESC internal operational policy and procedure document [effective date: 06/26/2015] Greg Jensen, Director of Administrative Services

More information

Naloxone Distribution for Opioid Overdose Prevention

Naloxone Distribution for Opioid Overdose Prevention Naloxone Distribution for Opioid Overdose Prevention Caleb Banta-Green PhD, MPH, MSW Alcohol and Drug Abuse Institute, University of Washington Alan Melnick, MD, MPH Clark County Public Health Chris Humberson,

More information

P U B L I C H E A L T H A D V I S O R Y

P U B L I C H E A L T H A D V I S O R Y The Commonwealth of Massachusetts Executive Office of Health and Human Services Department of Public Health 250 Washington Street, Boston, MA 02108-4619Tel: 617-624-6000 Fax: 617-624-5206 www.mass.gov/dph

More information

First on the Scene: People Who Use Drugs, their Families and their Friends. Sharon Stancliff, MD, FAAFP Harm Reduction Coalition New York, NY

First on the Scene: People Who Use Drugs, their Families and their Friends. Sharon Stancliff, MD, FAAFP Harm Reduction Coalition New York, NY First on the Scene: People Who Use Drugs, their Families and their Friends Sharon Stancliff, MD, FAAFP Harm Reduction Coalition New York, NY A brief history with a common theme Chicago 1996: Chicago Recovery

More information

STATUS OF THE COMPREHENSIVE DRUG OVERDOSE PREVENTION PILOT PROGRAM IN LOS ANGELES COUNTY AND RELATED LEGISLATIVE POLICY

STATUS OF THE COMPREHENSIVE DRUG OVERDOSE PREVENTION PILOT PROGRAM IN LOS ANGELES COUNTY AND RELATED LEGISLATIVE POLICY JONATHAN E. FIELDING, M.D., M.P.H. Director and Health Omcer JONATHAN E. FREEDMAN Ading Chief Deputy 313 Nolth Figueroa Street. Room 806 LOS Angeles, California 90012 TEL (213) 240-8117 FAX (213) 975-1273

More information

Treatments for drug misuse

Treatments for drug misuse Understanding NICE guidance Information for people who use NHS services Treatments for drug misuse NICE clinical guidelines advise the NHS on caring for people with specific conditions or diseases and

More information

The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section

The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section The Heroin and Prescription Drug Abuse Prevention and Reduction Act Section by Section TITLE I: PREVENTION SUBTITLE A- PRESCRIBER EDUCATION PRACTITIONER EDUCATION This subtitle requires practitioners who

More information

Discontinuation: Involuntary Discharge

Discontinuation: Involuntary Discharge Discontinuation: Involuntary Discharge TYPICALLY A PROCESS NOT AN EVENT Objectives 2 Review indications for discharge. Develop a therapeutic approach, in the context of the nature of Substance Use Disorders.

More information

drug treatment in england: the road to recovery

drug treatment in england: the road to recovery The use of illegal drugs in England is declining; people who need help to overcome drug dependency are getting it quicker; and more are completing their treatment and recovering drug treatment in ENGlaND:

More information

A Multi-Centre Efficacy Trial of Naltrexone Maintenance Therapy in Hong Kong

A Multi-Centre Efficacy Trial of Naltrexone Maintenance Therapy in Hong Kong A Multi-Centre Efficacy Trial of Naltrexone Maintenance Therapy in Hong Kong Executive Summary 1. Study Background 1.1 In May 1999, upon the recommendations of the Action Committee Against Narcotics (ACAN)

More information

DEVELOPING MANUFACTURING SUPPLYING. Naltrexone Implants. Manufactured by NalPharm Ltd WWW.NALPHARM.COM

DEVELOPING MANUFACTURING SUPPLYING. Naltrexone Implants. Manufactured by NalPharm Ltd WWW.NALPHARM.COM DEVELOPING MANUFACTURING SUPPLYING Naltrexone Implants Background to Nalpharm NalPharm is a specialist pharmaceutical company supplying proprietary branded medications and generic drugs in the area of

More information

Treatment Approaches for Drug Addiction

Treatment Approaches for Drug Addiction Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call 1-800-662-HELP(4357)

More information

Presentation to the Boston HIV Planning Council. Lydie Ultimo, MSW Director Bureau of Substance Abuse Services

Presentation to the Boston HIV Planning Council. Lydie Ultimo, MSW Director Bureau of Substance Abuse Services Presentation to the Boston HIV Planning Council Lydie Ultimo, MSW Director Bureau of Substance Abuse Services Responsibilities of the Bureau of Substance Abuse Services License addiction treatment programs

More information

Adult drug treatment plan 2009/10. Part 1: Strategic summary, needs assessment and key priorities

Adult drug treatment plan 2009/10. Part 1: Strategic summary, needs assessment and key priorities Birmingham Drug and Alcohol Action Team Adult drug treatment plan 2009/10 Part 1: Strategic summary, needs assessment and key priorities The strategic summary incorporating the findings of the needs assessment,

More information

THE DEDHAM COALITION FOR ALCOHOL AND DRUG AWARENESS

THE DEDHAM COALITION FOR ALCOHOL AND DRUG AWARENESS THE DEDHAM COALITION FOR ALCOHOL AND DRUG AWARENESS March 11 2014 Goals for the Presentation 2 Raise awareness and educate residents about substance use problems in our community Share information about

More information

BUILDING RECOVERY IN COMMUNITIES www.nta.nhs.uk

BUILDING RECOVERY IN COMMUNITIES www.nta.nhs.uk Parents with drug problems present real risks to their children. But drug treatment helps them to overcome their addiction and look after their children better PARENTS WITH DRUG PROBLEMS: HOW TREATMENT

More information

Treatment Approaches for Drug Addiction

Treatment Approaches for Drug Addiction Treatment Approaches for Drug Addiction [NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call

More information

Combating Opiate Addiction

Combating Opiate Addiction Combating Opiate Addiction A Strategy by the Arlington Police Department A Plan of Action Frederick Ryan Chief of Police July 2015 Statement of the Problem The recent heroin epidemic has spared no community

More information

Phoenix House. Outpatient Treatment Services for Adults in Los Angeles and Orange Counties

Phoenix House. Outpatient Treatment Services for Adults in Los Angeles and Orange Counties Phoenix House Outpatient Treatment Services for Adults in Los Angeles and Orange Counties Phoenix House s outpatient programs offer comprehensive and professional clinical services that include intervention,

More information

Opioid Overdose in Western Massachusetts Springfield and Western Counties compared to statewide data

Opioid Overdose in Western Massachusetts Springfield and Western Counties compared to statewide data Volume #1 October 2015 PUBLIC HEALTH ISSUE BRIEF Opioid Overdose in Western Massachusetts Springfield and Western Counties compared to statewide data October 2015 Partners for a Healthier Community, Inc.

More information

Frequently asked questions

Frequently asked questions Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently asked questions What is Naltrexone? Naltrexone is a prescription drug that completely blocks the effects of all opioid drugs

More information

The Opiate Epidemic. Laura Suminski, MSE, NCC, LPC-IT, SAC-IT Krystle Gutting, MS, LPC-IT, SAC-IT

The Opiate Epidemic. Laura Suminski, MSE, NCC, LPC-IT, SAC-IT Krystle Gutting, MS, LPC-IT, SAC-IT The Opiate Epidemic Laura Suminski, MSE, NCC, LPC-IT, SAC-IT Krystle Gutting, MS, LPC-IT, SAC-IT Connections Counseling Madison, WI www.connectionscounseling.com The Opiate Epidemic Opioid-related Facts

More information

Benzodiazepine Detoxification and Reduction of Long term Use

Benzodiazepine Detoxification and Reduction of Long term Use Benzodiazepine Detoxification and Reduction of Long term Use Malcolm Lader 1 Model of general drug misuse and dependence. Tactical interventional options Social dimension Increasing breaking of social

More information

Southlake Psychiatry. Suboxone Contract

Southlake Psychiatry. Suboxone Contract Suboxone Contract Thank you for considering Southlake Psychiatry for your Suboxone treatment. Opiate Addiction is a serious condition for which you may find relief with Suboxone treatment. In order to

More information

POLICY AND PROCEDURES FOR PROVIDING NARCOTIC ADDICTION TREATMENT TO PREGNANT OPIOID DEPENDENT INMATES INCARCERATED IN THE COUNTY JAIL

POLICY AND PROCEDURES FOR PROVIDING NARCOTIC ADDICTION TREATMENT TO PREGNANT OPIOID DEPENDENT INMATES INCARCERATED IN THE COUNTY JAIL PURPOSE POLICY AND PROCEDURES FOR PROVIDING NARCOTIC ADDICTION TREATMENT TO PREGNANT OPIOID DEPENDENT INMATES INCARCERATED IN THE COUNTY JAIL To outline the procedures used in recognizing and providing

More information

How To Treat A Drug Addiction

How To Treat A Drug Addiction 1 About drugs Drugs are substances that change a person s physical or mental state. The vast majority of drugs are used to treat medical conditions, both physical and mental. Some, however, are used outside

More information

Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio

Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio Governor s Cabinet Opiate Action Team Promoting Wellness and Recovery John R. Kasich, Governor Tracy J. Plouck, Director Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio November 14,

More information

REVIEW OF DRUG TREATMENT AND REHABILITATION SERVICES: SUMMARY AND ACTIONS

REVIEW OF DRUG TREATMENT AND REHABILITATION SERVICES: SUMMARY AND ACTIONS REVIEW OF DRUG TREATMENT AND REHABILITATION SERVICES: SUMMARY AND ACTIONS 1. INTRODUCTION 1.1 Review Process A Partnership for a Better Scotland committed the Scottish Executive to reviewing and investing

More information

IN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act

IN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act IN THE GENERAL ASSEMBLY STATE OF Ensuring Access to Medication Assisted Treatment Act 1 Be it enacted by the People of the State of Assembly:, represented in the General 1 1 1 1 Section 1. Title. This

More information

TRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013

TRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013 2013 to 2002 States: United the in Use Heroin in Trends National Survey on Drug Use and Health Short Report April 23, 2015 TRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013 AUTHORS Rachel N. Lipari,

More information

The NJSAMS Report. Heroin Admissions to Substance Abuse Treatment in New Jersey. In Brief. New Jersey Substance Abuse Monitoring System.

The NJSAMS Report. Heroin Admissions to Substance Abuse Treatment in New Jersey. In Brief. New Jersey Substance Abuse Monitoring System. New Jersey Substance Abuse Monitoring System The NJSAMS Report May 2011 Admissions to Substance Abuse Treatment in New Jersey eroin is a semi-synthetic opioid drug derived from morphine. It has a high

More information

Non medical use of prescription medicines existing WHO advice

Non medical use of prescription medicines existing WHO advice Non medical use of prescription medicines existing WHO advice Nicolas Clark Management of Substance Abuse Team WHO, Geneva Vienna, June 2010 clarkn@who.int Medical and Pharmaceutical role Recommendations

More information

Celebrating a Year of Expanded Naloxone Access and Overdose Education within Cuyahoga County

Celebrating a Year of Expanded Naloxone Access and Overdose Education within Cuyahoga County Cuyahoga County March 2014, Issue 1 Celebrating a Year of Expanded Naloxone Access and Overdose Education within Cuyahoga County According to the Ohio Department of Health (ODH), between 1999 and 2011,

More information

John R. Kasich, Governor Orman Hall, Director

John R. Kasich, Governor Orman Hall, Director John R. Kasich, Governor Orman Hall, Director 2 3 Epidemics of unintentional drug overdoses in Ohio, 1979-2011 1,2,3 1800 1600 1400 1200 1000 800 Prescription drugs are causing a larger overdose epidemic

More information

Mental Health Care in Spain

Mental Health Care in Spain Reform in Spain Universal health coverage, predominantly funded through general taxation Mental in Spain Dr. Marta Torrens. Institute of Neuropsychiatry & Addictions-Parc de Salut Mar. Universitat Autònoma

More information

Jennifer Sharpe Potter, PhD, MPH Associate Professor Division of Alcohol and Drug Addiction Department of Psychiatry

Jennifer Sharpe Potter, PhD, MPH Associate Professor Division of Alcohol and Drug Addiction Department of Psychiatry Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings From Starting Treatment With Agonist Replacement Therapies (START) Jennifer

More information

Costing report. Drug misuse: psychosocial interventions and opioid detoxification. Implementing NICE guidance. July 2007

Costing report. Drug misuse: psychosocial interventions and opioid detoxification. Implementing NICE guidance. July 2007 Drug misuse: psychosocial interventions and opioid detoxification Costing report Implementing NICE guidance July 2007 NICE clinical guidelines 51 and 52 National costing report: Drug misuse guidelines

More information

N-ALIVE: Randomised Trial of Naloxone-On-Release to Prevent Heroin Overdose Deaths on Prison Release in England

N-ALIVE: Randomised Trial of Naloxone-On-Release to Prevent Heroin Overdose Deaths on Prison Release in England N-ALIVE: Randomised Trial of Naloxone-On-Release to Prevent Heroin Overdose Deaths on Prison Release in England Professor John Strang National Addiction Centre, London, UK (on behalf of co-investigators

More information

Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions

Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently Asked Questions What is Naltrexone? Naltrexone is a prescription drug that effectively blocks the effects of heroin, alcohol,

More information

Updated on Substance Abuse Treatment Centers in New Mexico

Updated on Substance Abuse Treatment Centers in New Mexico Updated on Substance Abuse Treatment Centers in New Mexico Update on Substance Abuse Treatment Centers in New Mexico Presentation to: The Legislative Health and Human Services Committee Wayne W. Lindstrom,

More information

Allyse Adams PC, LICDC Oriana House, Inc.

Allyse Adams PC, LICDC Oriana House, Inc. Allyse Adams PC, LICDC Oriana House, Inc. 98 Heroin Overdose Deaths from 1/1/2015-7/26/2015 Last year enough narcotic pain medicines were prescribed to supply 67 pills to every man, woman and child In

More information

THE CAUSES OF DRUG ADDICTION

THE CAUSES OF DRUG ADDICTION 1 Statistical facts associated with addiction and substance abuse are concerning, but many men and women choose to ignore the dangers. By understanding the main causes of addiction to drugs, it is possible

More information

A COLLABORATIVE PRACTICE AGREEMENT FOR OPIOID OVERDOSE PREVENTION AND RESPONSE NALOXONE OVERDOSE KIT DISTRIBUTION PROTOCOL

A COLLABORATIVE PRACTICE AGREEMENT FOR OPIOID OVERDOSE PREVENTION AND RESPONSE NALOXONE OVERDOSE KIT DISTRIBUTION PROTOCOL A COLLABORATIVE PRACTICE AGREEMENT FOR OPIOID OVERDOSE PREVENTION AND RESPONSE NALOXONE OVERDOSE KIT DISTRIBUTION PROTOCOL Purpose: To reduce morbidity and mortality from opioid overdose. Policy: Under

More information

Heroin Overdose Trends and Treatment Options. Neil A. Capretto, D.O., F.A.S.A.M. Medical Director

Heroin Overdose Trends and Treatment Options. Neil A. Capretto, D.O., F.A.S.A.M. Medical Director Heroin Overdose Trends and Treatment Options Neil A. Capretto, D.O., F.A.S.A.M. Medical Director Type date here www.gatewayrehab.org Drug Overdose Deaths Increasing in Allegheny County Roberta Lojak holds

More information

Integrated drug treatment system Treatment plan 2009/10. Part 1: Strategic summary, needs assessment and key priorities

Integrated drug treatment system Treatment plan 2009/10. Part 1: Strategic summary, needs assessment and key priorities Establishment: HMP Belmarsh Drugs partnership: Greenwich Primary Care Trust: Greenwich Integrated drug treatment system Treatment plan 2009/10 Part 1: Strategic summary, needs assessment and key priorities

More information

The story of drug treatment

The story of drug treatment EFFECTIVE TREATMENT CHANGING LIVES www.nta.nhs.uk www.nta.nhs.uk 1 The story of drug treatment The use of illicit drugs is declining in England; more and more people who need help with drug dependency

More information

ACMD. Consideration of naloxone. Advisory Council on the Misuse of Drugs. May 2012. Page 1 of 37

ACMD. Consideration of naloxone. Advisory Council on the Misuse of Drugs. May 2012. Page 1 of 37 ACMD Advisory Council on the Misuse of Drugs Consideration of naloxone May 2012 Page 1 of 37 ACMD Advisory Council on the Misuse of Drugs Anne Milton MP Parliamentary Under-Secretary of State for Public

More information

Prescriber Behavior, Pain Treatment and Addiction Treatment

Prescriber Behavior, Pain Treatment and Addiction Treatment Prescriber Behavior, Pain Treatment and Addiction Treatment Mary Fleming, M.S. Director, Office of Policy, Planning, and Innovation Substance Abuse and Mental Health Services Administration NGA Policy

More information

Specialist Alcohol & Drug Services in Lanarkshire

Specialist Alcohol & Drug Services in Lanarkshire Specialist Alcohol & Drug Services in Lanarkshire This brochure describes what help is available within Lanarkshire s specialist treatment services. These include the North Lanarkshire Integrated Addiction

More information

DRAFT OVERDOSE ASSESSMENT, RESPONSE AND TREATMENT POLICY FOR SELECTED ADULT FACILITES

DRAFT OVERDOSE ASSESSMENT, RESPONSE AND TREATMENT POLICY FOR SELECTED ADULT FACILITES 1 DRAFT OVERDOSE ASSESSMENT, RESPONSE AND TREATMENT POLICY FOR SELECTED ADULT FACILITES PURPOSE To provide guidelines for staff response when a client is found unconscious or not breathing. APPLICABILITY

More information

Medications to address the opioid crisis - methadone, buprenorphine, naltrexone, and naloxone

Medications to address the opioid crisis - methadone, buprenorphine, naltrexone, and naloxone Medications to address the opioid crisis - methadone, buprenorphine, naltrexone, and naloxone Alexander Y. Walley, MD, MSc Director, Addiction Medicine Fellowship and Addiction Medicine Consult Service

More information

FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma

FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma Background A growing opiate abuse epidemic has highlighted the need for effective treatment options. This study documents

More information

Current Model of Drug Care. Components of a Full Drug Care Service

Current Model of Drug Care. Components of a Full Drug Care Service Current Model of Drug Care Treatment Detox Rehab Components of a Full Drug Care Service (1) (2) (3) (4) (5) (6) (7) (8) (9) Community Preparation Treatment Detox Rehab Community Community Prison work Halfway

More information

THE DRUG DETOX UNIT AT MOUNTJOY PRISON A REVIEW

THE DRUG DETOX UNIT AT MOUNTJOY PRISON A REVIEW 1 THE DRUG DETOX UNIT AT MOUNTJOY PRISON A REVIEW By Dr. Des Crowley, General Practitioner INTRODUCTION The Drug Detox Unit was opened in July 1996 at Mountjoy Prison in response to the escalating drug

More information

A Local Multifaceted, Multidisciplinary Approach to Opiate Overdose & Death

A Local Multifaceted, Multidisciplinary Approach to Opiate Overdose & Death A Local Multifaceted, Multidisciplinary Approach to Opiate Overdose & Death 2013 WPHA-WALHDAB Annual Conference Wednesday, May 22: 2:00-2:35 pm Lisa Bullard-Cawthorne, MS, MPH OPIATE PREVALENCE IN DANE

More information

The VEdeTTE cohort study: Effectiveness of treatments for heroin addiction in retaining patients and reducing mortality

The VEdeTTE cohort study: Effectiveness of treatments for heroin addiction in retaining patients and reducing mortality The VEdeTTE cohort study: Effectiveness of treatments for heroin addiction in retaining patients and reducing mortality Federica Vigna-Taglianti www.oed.piemonte.it Piedmont Centre for Drug Addiction Epidemiology

More information

Key Questions to Consider when Seeking Substance Abuse Treatment

Key Questions to Consider when Seeking Substance Abuse Treatment www.ccsa.ca www.cclt.ca Frequently Asked Questions Key Questions to Consider when Seeking Substance Abuse Treatment The Canadian Centre on Substance Abuse (CCSA) has developed this document to address

More information

SOMERSET DUAL DIAGNOSIS PROTOCOL OCTOBER 2011

SOMERSET DUAL DIAGNOSIS PROTOCOL OCTOBER 2011 SOMERSET DUAL DIAGNOSIS PROTOCOL OCTOBER 2011 This document is intended to be used with the Somerset Dual Diagnosis Operational Working guide. This document provides principles governing joint working

More information

Opioid overdose can occur when a patient misunderstands the directions

Opioid overdose can occur when a patient misunderstands the directions Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription

More information

John R. Kasich, Governor Tracy J. Plouck, Director. Rick Massatti, PhD Brad DeCamp, MPA

John R. Kasich, Governor Tracy J. Plouck, Director. Rick Massatti, PhD Brad DeCamp, MPA John R. Kasich, Governor Tracy J. Plouck, Director Rick Massatti, PhD Brad DeCamp, MPA Overdose episodes are increasing According to the EMS Reporting Incident System, the number of potentially drug-related

More information

Minimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment:

Minimum Insurance Benefits for Patients with Opioid Use Disorder The Opioid Use Disorder Epidemic: The Evidence for Opioid Treatment: Minimum Insurance Benefits for Patients with Opioid Use Disorder By David Kan, MD and Tauheed Zaman, MD Adopted by the California Society of Addiction Medicine Committee on Opioids and the California Society

More information

To detox or not to detox: whose choice is it anyway? Dr Ed Day Senior Lecturer in Addiction Psychiatry University of Birmingham

To detox or not to detox: whose choice is it anyway? Dr Ed Day Senior Lecturer in Addiction Psychiatry University of Birmingham To detox or not to detox: whose choice is it anyway? Dr Ed Day Senior Lecturer in Addiction Psychiatry University of Birmingham What do people say they want? Luty J (2004) 104 people attending a community

More information

WHAT HAPPENS TO OUR BRAIN?

WHAT HAPPENS TO OUR BRAIN? WORK DYNAMIC The final result of this session is the formulation of the questions that, within the activity of the Let s talk about drugs programme of the la Caixa Welfare Project, you will ask Dr. Rafael

More information

NOUVELLE PRÉOCCUPATION CONCERNANT LA TRANSMISSION DU VIRUS DE L HÉPATITE C CHEZ LES USAGERS DE DROGUES INJECTABLES À MONTRÉAL, CANADA

NOUVELLE PRÉOCCUPATION CONCERNANT LA TRANSMISSION DU VIRUS DE L HÉPATITE C CHEZ LES USAGERS DE DROGUES INJECTABLES À MONTRÉAL, CANADA Le Colloque Européen et International THS Biarritz,11 au 14 octobre 2011 NOUVELLE PRÉOCCUPATION CONCERNANT LA TRANSMISSION DU VIRUS DE L HÉPATITE C CHEZ LES USAGERS DE DROGUES INJECTABLES À MONTRÉAL, CANADA

More information

Drug Abuse Trends in the Seattle/King County Area: 2013

Drug Abuse Trends in the Seattle/King County Area: 2013 Drug Abuse Trends in the Seattle/King County Area: 2013 Caleb Banta-Green 1, T. Ron Jackson 2, Steve Freng 3, Michael Hanrahan 4, Cynthia Graff 5, John Ohta 6, Mary Taylor 7, Richard Harruff 8, Robyn Smith

More information

Drug Abuse Patterns and Trends in the San Francisco Bay Area Update: June 2014

Drug Abuse Patterns and Trends in the San Francisco Bay Area Update: June 2014 Drug Abuse Patterns and Trends in the San Francisco Bay Area Update: June 24 Alice A. Gleghorn, Ph.D. ABSTRACT In San Francisco, increases in heroin consequence indicators (treatment admissions and Drug

More information

Tolerance and Dependence

Tolerance and Dependence Tolerance and Dependence Drug Tolerance is a decrease in the effect of a drug as a consequence of repeated exposure. Change over repeated exposures. Different effects may show different tolerance. Tolerance

More information

In 2010, approximately 8 million Americans 18 years and older were dependent on alcohol.

In 2010, approximately 8 million Americans 18 years and older were dependent on alcohol. Vivitrol Pilot Study: SEMCA/Treatment Providers Collaborative Efforts with the treatment of Opioid Dependent Clients Hakeem Lumumba, PhD, CAADC SEMCA Scott Schadel, MSW, LMSW, CAADC HEGIRA PROGRAMS, INC.

More information

DMRI Drug Misuse Research Initiative

DMRI Drug Misuse Research Initiative DMRI Drug Misuse Research Initiative Executive Summary Dexamphetamine Substitution as a Treatment of Amphetamine Dependence: a Two-Centre Randomised Controlled Trial Final Report submitted to the Department

More information

Addressing Alcohol and Drugs in the Community. Cabinet member: Cllr Keith Humphries - Public Health and Protection Services

Addressing Alcohol and Drugs in the Community. Cabinet member: Cllr Keith Humphries - Public Health and Protection Services Wiltshire Council Cabinet 17 April 2012 Subject: Addressing Alcohol and Drugs in the Community Cabinet member: Cllr Keith Humphries - Public Health and Protection Services Key Decision: Yes Executive Summary

More information

Title: The Certified Medication Assisted Treatment Advocate (CMA) Training Course

Title: The Certified Medication Assisted Treatment Advocate (CMA) Training Course The American Association for the Treatment of Opioid Dependence, provider #1044, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org,

More information

Getting help for a drug problem A guide to treatment

Getting help for a drug problem A guide to treatment Getting help for a drug problem A guide to treatment Who we are The National Treatment Agency for Substance Misuse is part of the National Health Service. We were set up in 2001 to increase the numbers

More information

OPTUM By United Behavioral Health OPTUM GUIDELINE EVIDENCE BASE: Level of Care Guidelines

OPTUM By United Behavioral Health OPTUM GUIDELINE EVIDENCE BASE: Level of Care Guidelines OPTUM By United Behavioral Health OPTUM GUIDELINE EVIDENCE BASE: Level of Care Guidelines Guideline Evaluation and Treatment Planning Discharge Planning Admission Criteria Continued Stay Criteria Discharge

More information

The Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction

The Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction The Results of a Pilot of Vivitrol: A Medication Assisted Treatment for Alcohol and Opioid Addiction James H. Barger, MD SAPC Medical Director and Science Officer Desiree A. Crevecoeur-MacPhail, Ph.D.

More information

Joint Committee on Health and Children

Joint Committee on Health and Children Houses of the Oireachtas Joint Committee on Health and Children A Submission From Homeless & Drugs Services Homeless & Drugs Services September 15 th 2011 1 CONTENTS Page no. 0.1 Introduction 3 0.2 Structure

More information

Patient Information and Consent to Treatment with Buprenorphine

Patient Information and Consent to Treatment with Buprenorphine 1063 Lower Main St, Ste C212 JEFFREY H. CHESTER, DO Phone 808.249.8887-6006 www.ponohealthcare.com Board Certified by American Board of Physical Medicine & Rehabilitation Board Certified by American Society

More information

Naloxone Distribution and Cardiopulmonary Resuscitation Training for Injection Drug Users to Prevent Heroin Overdose Death: A Pilot Intervention Study

Naloxone Distribution and Cardiopulmonary Resuscitation Training for Injection Drug Users to Prevent Heroin Overdose Death: A Pilot Intervention Study Journal of Urban Health: Bulletin of the New York Academy of Medicine, Vol. 82, No. 2, doi:10.1093/jurban/jti053 The Author 2005. Published by Oxford University Press on behalf of the New York Academy

More information

This presentation is going to discuss the BLS use of Intranasal naloxone. Naloxone is the generic name while Narcan is the trade name.

This presentation is going to discuss the BLS use of Intranasal naloxone. Naloxone is the generic name while Narcan is the trade name. Welcome! 1 This presentation is going to discuss the BLS use of Intranasal naloxone. Naloxone is the generic name while Narcan is the trade name. 2 Definitive treatment for an opioid or opiate overdose

More information

Methadone for Substance Abuse. By: Angela M. Martinez

Methadone for Substance Abuse. By: Angela M. Martinez Methadone for Substance Abuse By: Angela M. Martinez When taken orally once a day, methadone suppresses narcotic withdrawal for between 24 and 36 hours. Because methadone is effective in eliminating withdrawal

More information

Treatment of opioid use disorders

Treatment of opioid use disorders Treatment of opioid use disorders Gerardo Gonzalez, MD Associate Professor of Psychiatry Director, Division of Addiction Psychiatry Disclosures I have no financial conflicts to disclose I will review evidence

More information

Baby Boomers and Substance Abuse Treatment

Baby Boomers and Substance Abuse Treatment The Abbey Foundation Baby Boomers and Substance Abuse Treatment Punit Sharma Bettendorf, Iowa Date: August 5 th, 2009 Baby Boomers and Substance Abuse Treatment 1 Introduction The term Baby Boomer refers

More information

- NALOXONE/NARCAN. This training is designed to teach you about one action you can take in case of an overdose of opiates.

- NALOXONE/NARCAN. This training is designed to teach you about one action you can take in case of an overdose of opiates. OVERDOSE MANAGEMENT PROTOCOL - NALOXONE/NARCAN TRAINING This training is designed to teach you about one action you can take in case of an overdose of opiates. This training program will not make you a

More information

Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy

Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy Category: Heroin Title: Methadone Maintenance vs 180-Day psychosocially Enriched Detoxification for Treatment of Opioid Dependence: A Randomized Controlled Trial Authors: Karen L. Sees, DO, Kevin L. Delucchi,

More information

Data-Driven Multi-Disciplinary Approaches to Reducing Rx Abuse, BJA Award FY 2014

Data-Driven Multi-Disciplinary Approaches to Reducing Rx Abuse, BJA Award FY 2014 Data-Driven Multi-Disciplinary Approaches to Reducing Rx Abuse, BJA Award FY 2014 Denise Paone and Alexandra Harocopos Bureau of Alcohol & Drug Use Prevention, Care & Treatment New York City Department

More information

MORTALITY AMONGST ILLICIT DRUG USERS

MORTALITY AMONGST ILLICIT DRUG USERS MORTALITY AMONGST ILLICIT DRUG USERS Over the past 40 years the rate of illicit drug use worldwide has risen dramatically, and with it the number of deaths reported among drug-using populations. What are

More information

Jane Maxwell, UT Addiction Research Institute, 512 232-0610. Prescription Pain Medications and Heroin: A Changing Picture

Jane Maxwell, UT Addiction Research Institute, 512 232-0610. Prescription Pain Medications and Heroin: A Changing Picture Prescription Pain Medications and : A Changing Picture Jane Maxwell, Ph.D. Center for Social Work Research The University of Texas at Austin Disclosure to Participants Commercial Support: This educational

More information